Insider Trading Activity Tabula Rasa HealthCare (NASDAQ:TRHC) – CEO Sold 8,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Tabula Rasa HealthCare (NASDAQ:TRHC)

Calvin H Knowlton , CEO of Tabula Rasa HealthCare (NASDAQ:TRHC) reportedly Sold 8,000 shares of the company’s stock at an average price of 53.94 for a total transaction amount of $431,520.00 SEC Form

Insider Trading History For Tabula Rasa HealthCare (NASDAQ:TRHC)

  • On 10/4/2016 Joann M Durham, Major Shareholder, sold 4,070 with an average share price of $12.00 per share and the total transaction amounting to $48,840.00.
  • On 10/4/2016 Glen R Bressner, Director, bought 8,500 with an average share price of $12.00 per share and the total transaction amounting to $102,000.00.
  • On 5/17/2017 Orsula V Knowlton, Insider, sold 8,000 with an average share price of $11.94 per share and the total transaction amounting to $95,520.00.
  • On 5/18/2017 Glen R Bressner, Director, bought 7,500 with an average share price of $11.96 per share and the total transaction amounting to $89,700.00.
  • On 6/12/2017 Gordon Tunstall, Director, sold 22,759 with an average share price of $13.76 per share and the total transaction amounting to $313,163.84.
  • On 6/14/2017 Orsula V. Knowlton, Insider, sold 8,000 with an average share price of $14.02 per share and the total transaction amounting to $112,160.00.
  • On 7/19/2017 Orsula V Knowlton, Insider, sold 8,000 with an average share price of $14.20 per share and the total transaction amounting to $113,600.00.

    • Analyst Ratings History For Tabula Rasa HealthCare (NASDAQ:TRHC)

    • On 7/14/2017 Stifel Nicolaus Reiterated Rating Buy with a price target of $16.00
    • On 8/30/2017 UBS Group Boost Price Target of rating Buy ➝ Buy with a price target of $18.00 ➝ $25.00
    • On 10/17/2017 Robert W. Baird Reiterated Rating Outperform with a price target of $22.00 ➝ $30.00
    • On 10/19/2017 Wells Fargo & Co Boost Price Target of rating Market Perform with a price target of $21.00 ➝ $27.00
    • On 11/1/2017 First Analysis Initiated Coverage of rating Overweight with a price target of $41.00
    • On 3/13/2018 William Blair Reiterated Rating Outperform
    • On 3/13/2018 Oppenheimer Boost Price Target of rating Outperform with a price target of $35.00 ➝ $47.00

    Recent Trading Activity for Tabula Rasa HealthCare (NASDAQ:TRHC)
    Shares of Tabula Rasa HealthCare closed the previous trading session at 51.20 down -3.81 6.93% with 55.13999938964844 shares trading hands.